Minor adverse events assessed: related to intervention only (e.g. redness) · COPD
NMES showed no clear difference in minor adverse events assessed: related to intervention only (e.g.… compared with usual care (with or without sham NMES) (low certainty).
1 finding from 1 review
Exacerbations · autumn asthma exacerbations in children
Omalizumab probably leads to lower exacerbations compared with usual care (moderate certainty).
3 findings from 1 review
OR 0.48 [0.25, 0.92]
1 study · 348 participants
Moderate
OR 0.37 [0.17, 0.81]
1 study · 184 participants
Moderate
OR 0.63 [0.22, 1.79]
1 study · 164 participants
Moderate
Exacerbations · autumn asthma exacerbations in children
The review found no eligible studies for this question.
2 findings from 1 review
Adverse events · autumn asthma exacerbations in children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · autumn asthma exacerbations in children
Omalizumab showed no clear difference in adverse events compared with usual care (moderate certainty).
1 finding from 1 review
Exacerbations · autumn asthma exacerbations in children
A boost of inhaled corticosteroids showed no clear difference in exacerbations compared with usual care (moderate certainty).
1 finding from 1 review
Adverse events · autumn asthma exacerbations in children
A boost of inhaled corticosteroids showed no clear difference in adverse events compared with usual care (moderate certainty).
1 finding from 1 review
Exacerbations · autumn asthma exacerbations in children
The review found no eligible studies for this question.
2 findings from 1 review
Adverse events · autumn asthma exacerbations in children
Leukotriene receptor antagonist showed no clear difference in adverse events compared with usual care (high certainty).
1 finding from 1 review
Health‐related quality of life · people with non‐cystic fibrosis bronchiectasis
2 findings from 1 review
Exacerbations requiring antibiotics · people with non‐cystic fibrosis bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events: mortality · people with non‐cystic fibrosis bronchiectasis
1 finding from 1 review
Hospital admissions · people with non‐cystic fibrosis bronchiectasis
1 finding from 1 review
Lung function · people with non‐cystic fibrosis bronchiectasis
1 finding from 1 review
Self‐efficacy · people with non‐cystic fibrosis bronchiectasis
1 finding from 1 review
Costs · people with non‐cystic fibrosis bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
All‐cause mortality · Patients admitted to hospital with acute hypercapnic respiratory failure due to an exacerbation of chronic obstructive pulmonary disease…
Non‐invasive ventilation probably leads to lower mortality compared with usual medical care (moderate certainty).
1 finding from 1 review
Need for intubation · Patients admitted to hospital with acute hypercapnic respiratory failure due to an exacerbation of chronic obstructive pulmonary disease…
Non‐invasive ventilation probably leads to lower need for endotracheal intubation compared with usual medical care (moderate certainty).
1 finding from 1 review
Length of hospital stay · Patients admitted to hospital with acute hypercapnic respiratory failure due to an exacerbation of chronic obstructive pulmonary disease…
1 finding from 1 review
Correct inhaler technique · people with asthma
Enhanced education probably leads to higher correct inhaler technique compared with control versus usual care (moderate certainty).
1 finding from 1 review